Savara SVRA In Process Research And Development
In Process Research And Development at other companies
Other financials
Where this comes from
Reported directly by Savara in its filing.
Tagged under the XBRL concept svra:InProcessResearchAndDevelopment.
The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Savara's in process research and development.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Savara's in process research and development?
- Savara (SVRA) reported in process research and development of $11.36M in Q1 2026.
- How has Savara's in process research and development changed year-over-year?
- Savara's in process research and development increased by 5.9% year-over-year, from $10.73M to $11.36M.
- What is the long-term trend for Savara's in process research and development?
- Over 5 years (2020 to 2025), Savara's in process research and development has grown at a -1.0% compound annual growth rate (CAGR), from $12.22M to $11.64M.
- What does in process research and development mean?
- This represents the capitalized value of research and development projects acquired through business combinations that have not yet reached technological feasibility. It reflects the investment in pipeline assets that are currently undergoing clinical trials or regulatory review. Monitoring this balance provides insight into the company's commitment to future product commercialization and the potential long-term value of its therapeutic pipeline.